Vaccines,
Год журнала:
2024,
Номер
12(5), С. 467 - 467
Опубликована: Апрель 27, 2024
Public
antibody
responses
have
been
found
against
many
infectious
agents.
Structural
convergence
of
public
antibodies
is
usually
determined
by
immunoglobulin
V
genes.
Recently,
a
human
class
SARS-CoV-2
was
reported,
where
the
D
gene
(IGHD3-22)
encodes
common
YYDxxG
motif
in
heavy-chain
complementarity-determining
region
3
(CDR
H3),
which
determines
specificity
for
receptor-binding
domain
(RBD).
In
this
review,
we
discuss
isolation,
structural
characterization,
and
genetic
analyses
antibodies,
isolated
from
various
cohorts
COVID-19
convalescents
vaccinees.
All
eleven
with
available
structures
target
RBD
similar
binding
mode,
CDR
H3
dominates
interaction
antigen.
The
conserved
site
on
that
does
not
overlap
site,
but
their
particular
angle
approach
results
direct
steric
hindrance
to
receptor
binding,
enables
both
neutralization
potency
breadth.
We
also
review
properties
H3-dominant
other
viruses.
Overall,
unlike
most
are
identified
usage,
newly
discovered
dominated
D-gene-encoded
uncovers
further
opportunities
germline-targeting
vaccine
design.
Signal Transduction and Targeted Therapy,
Год журнала:
2024,
Номер
9(1)
Опубликована: Май 13, 2024
Abstract
Almost
all
the
neutralizing
antibodies
targeting
receptor-binding
domain
(RBD)
of
spike
(S)
protein
show
weakened
or
lost
efficacy
against
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
emerged
emerging
variants,
such
as
Omicron
and
its
sub-variants.
This
suggests
that
highly
conserved
epitopes
are
crucial
for
development
antibodies.
Here,
we
present
one
nanobody,
N235,
displaying
broad
neutralization
SARS-CoV-2
prototype
multiple
including
newly
Cryo-electron
microscopy
demonstrates
N235
binds
a
novel,
conserved,
cryptic
epitope
in
N-terminal
(NTD)
S
protein,
which
interferes
with
RBD
neighboring
protein.
The
mechanism
interpreted
via
flow
cytometry
Western
blot
shows
appears
to
induce
S1
subunit
shedding
from
trimeric
complex.
Furthermore,
nano-IgM
construct
(MN235),
engineered
by
fusing
human
IgM
Fc
region,
displays
prevention
inducing
cross-linking
virus
particles.
Compared
MN235
exhibits
varied
enhancement
pseudotyped
authentic
viruses
vitro.
intranasal
administration
low
doses
can
effectively
prevent
infection
sub-variant
BA.1
XBB
vivo,
suggesting
it
be
developed
promising
prophylactic
antibody
cope
ongoing
future
infection.
Cell Reports,
Год журнала:
2024,
Номер
43(6), С. 114338 - 114338
Опубликована: Июнь 1, 2024
The
game
between
therapeutic
monoclonal
antibodies
(mAbs)
and
continuously
emerging
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
variants
has
favored
the
virus,
as
most
mAbs
have
been
evaded.
Addressing
this
challenge,
we
systematically
explored
a
reproducible
bispecific
antibody
(bsAb)-dependent
synergistic
effect
in
study.
It
could
effectively
restore
neutralizing
activity
of
bsAb
when
any
its
single
is
escaped
by
variants.
This
synergy
primarily
attributed
to
binding
angle
receptor-binding
domain
(RBD)-5,
facilitating
inter-spike
cross-linking
promoting
cryptic
epitope
exposure
that
classical
cocktails
cannot
achieve.
Furthermore,
RBD-5
with
RBD-2,
RBD-6,
RBD-7,
alongside
RBD-8,
also
exhibit
significantly
enhanced
effects.
study
not
only
shifts
paradigm
understanding
interactions
but
paves
way
for
developing
more
effective
against
rapidly
mutating
SARS-CoV-2,
Dia-19
already
showing
promise
like
BA.2.86,
EG.5.1,
JN.1.
Vaccines,
Год журнала:
2024,
Номер
12(7), С. 795 - 795
Опубликована: Июль 18, 2024
Immunity
against
respiratory
pathogens
is
often
short-term,
and,
consequently,
there
an
unmet
need
for
the
effective
prevention
of
such
infections.
One
infectious
disease
coronavirus
19
(COVID-19),
which
caused
by
novel
Beta
SARS-CoV-2
that
emerged
around
end
2019.
The
World
Health
Organization
declared
illness
a
pandemic
on
11
March
2020,
and
since
then
it
has
killed
or
sickened
millions
people
globally.
development
COVID-19
systemic
vaccines,
impressively
led
to
significant
reduction
in
severity,
hospitalization,
mortality,
contained
pandemic’s
expansion.
However,
these
vaccines
have
not
been
able
stop
virus
from
spreading
because
restricted
mucosal
immunity.
As
result,
breakthrough
infections
frequently
occurred,
new
strains
emerging.
Furthermore,
will
likely
continue
circulate
like
influenza
virus,
co-exist
with
humans.
upper
tract
nasal
cavity
are
primary
sites
infection
thus,
mucosal/nasal
vaccination
induce
response
virus’
transmission
warranted.
In
this
review,
we
present
status
both
approved
those
under
evaluation
clinical
trials.
our
approach
B-cell
peptide-based
applied
prime-boost
schedule
elicit
Cell Reports,
Год журнала:
2024,
Номер
43(5), С. 114235 - 114235
Опубликована: Май 1, 2024
Nanoparticle
vaccines
displaying
mosaic
receptor-binding
domains
(RBDs)
or
spike
(S)
from
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
other
sarbecoviruses
are
used
in
preparedness
against
potential
zoonotic
outbreaks.
Here,
we
describe
a
self-assembling
nanoparticle
using
lumazine
synthase
(LuS)
as
the
scaffold
to
display
RBDs
different
sarbecoviruses.
Mosaic
nanoparticles
induce
sarbecovirus
cross-neutralizing
antibodies
comparable
cocktail.
We
find
elicit
B
cell
receptor
repertoire
an
immunodominant
germline
gene
pair
of
IGHV14-3:IGKV14-111.
Most
tested
IGHV14-3:IGKV14-111
monoclonal
(mAbs)
broadly
cross-reactive
clade
1a,
1b,
and
3
Using
mAb
competition
cryo-electron
microscopy,
determine
that
representative
mAb,
M2-7,
binds
conserved
epitope
on
RBD,
largely
overlapping
with
pan-sarbecovirus
S2H97.
This
suggests
expand
recognition
common
epitopes
shared
by
clades
These
results
provide
immunological
insights
into
responses
elicited
Vaccines,
Год журнала:
2024,
Номер
12(5), С. 467 - 467
Опубликована: Апрель 27, 2024
Public
antibody
responses
have
been
found
against
many
infectious
agents.
Structural
convergence
of
public
antibodies
is
usually
determined
by
immunoglobulin
V
genes.
Recently,
a
human
class
SARS-CoV-2
was
reported,
where
the
D
gene
(IGHD3-22)
encodes
common
YYDxxG
motif
in
heavy-chain
complementarity-determining
region
3
(CDR
H3),
which
determines
specificity
for
receptor-binding
domain
(RBD).
In
this
review,
we
discuss
isolation,
structural
characterization,
and
genetic
analyses
antibodies,
isolated
from
various
cohorts
COVID-19
convalescents
vaccinees.
All
eleven
with
available
structures
target
RBD
similar
binding
mode,
CDR
H3
dominates
interaction
antigen.
The
conserved
site
on
that
does
not
overlap
site,
but
their
particular
angle
approach
results
direct
steric
hindrance
to
receptor
binding,
enables
both
neutralization
potency
breadth.
We
also
review
properties
H3-dominant
other
viruses.
Overall,
unlike
most
are
identified
usage,
newly
discovered
dominated
D-gene-encoded
uncovers
further
opportunities
germline-targeting
vaccine
design.